🧪 Ipamorelin & CJC-1295 No DAC 10mg: Advanced Research Profile
The Ipamorelin & CJC-1295 No DAC 10mg is a precision-engineered blend typically aggregating 5mg of Ipamorelin and 5mg of CJC-1295 (Modified GRF 1-29). Researchers utilizing the Ipamorelin & CJC-1295 No DAC 10mg focus on the “dual-family” receptor activation, which is theorized to produce a 3-5 fold increase in growth hormone release compared to individual peptide application.
-
Complementary Signaling: The Ipamorelin & CJC-1295 No DAC 10mg peptide is researched for its ability to target both GHRH receptors (CJC-1295) and ghrelin receptors (Ipamorelin), maximizing the endogenous growth hormone pulse.
-
Pulsatile Release Optimization: Studies on Ipamorelin & CJC-1295 No DAC 10mg indicate that the blend mimics natural physiologic rhythms, providing an immediate release “spark” from Ipamorelin and sustained elevation from CJC-1295.1
-
Selective Endocrine Action: The Ipamorelin & CJC-1295 No DAC 10mg formulation is investigated for its high specificity, stimulating GH without increasing stress markers such as ACTH, cortisol, or prolactin.2
-
Metabolic Signaling Synergy: Laboratory evaluations of Ipamorelin & CJC-1295 No DAC 10mg explore its capacity to improve lipid oxidation and nitrogen retention while stabilizing lean muscle density.
🔬 Key Research Applications of Ipamorelin & CJC-1295 No DAC 10mg
This specific blend is a primary focus for research models investigating:
-
🩹 Accelerated Tissue Recovery: Investigations into the effects of Ipamorelin & CJC-1295 No DAC 10mg on the repair of ligaments, tendons, and skeletal muscle analog constructs.
-
🧬 IGF-1 Pathway Modulation: Research into Ipamorelin & CJC-1295 No DAC 10mg regarding hepatic production of Insulin-like Growth Factor-1 and its role in secondary anabolic signaling.
-
🛡️ Circadian Rhythm & Sleep: Studies on the Ipamorelin & CJC-1295 No DAC 10mg look at its influence on deep slow-wave sleep stages and cognitive processing speed under stress.
-
🔥 Metabolic Homeostasis: Evaluation of Ipamorelin & CJC-1295 No DAC 10mg for its ability to reduce visceral fat accumulation and support cardiovascular hemodynamic markers.
✅ Ipamorelin & CJC-1295 No DAC 10mg Product Specifications
| Specification | Detail |
| Product Name | Ipamorelin & CJC-1295 No DAC 10mg |
| Ratio | 5mg Ipamorelin / 5mg CJC-1295 |
| Total Mass | 10 mg per vial |
| Appearance | White to off-white lyophilized powder |
| Format | Lyophilized powder for reconstitution |
| Solubility | Soluble in bacteriostatic water or sterile saline |
❄️ Product Care & Handling Guidelines
Proper storage is required to maintain the molecular integrity of the Ipamorelin & CJC-1295 No DAC 10mg synthesis.
-
Unreconstituted (Powder): Store Ipamorelin & CJC-1295 No DAC 10mg in a dry, dark place. Long-term storage is optimal at -20 degrees C.
-
Reconstituted (Liquid): Refrigerate Ipamorelin & CJC-1295 No DAC 10mg at 2 degrees C to 8 degrees C immediately; researchers typically use the solution within 7 to 14 days.
-
Handling Note: Peptides in the Ipamorelin & CJC-1295 No DAC 10mg blend are sensitive to mechanical stress. Use gentle swirling during reconstitution and avoid repeated freeze-thaw cycles.
📚 References & Resources
NCBI PubMed: https://pubmed.ncbi.nlm.nih.gov/16352683/
NCBI PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC7108996/
PubMed: https://pubmed.ncbi.nlm.nih.gov/9849822/
NCBI PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC4863553/
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC
⚠️ Laboratory Research Use Only Notice
The Ipamorelin & CJC-1295 No DAC 10mg product is strictly intended for in vitro and non-clinical laboratory research purposes only. It is not for human consumption, veterinary diagnostic, or therapeutic use. Statements regarding the biochemical potential of Ipamorelin & CJC-1295 No DAC 10mg have not been evaluated by the FDA. Researchers must follow established laboratory safety and ethical standards.
